AZTA — Stock Film
STOCK FILMSCENE 1/11AZTA · $30.85
Stock Expert AI presents
AZTA
Azenta, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Azenta, Inc. What it actually does.

Provides automated cold sample management systems for storing biological samples. Offers equipment for sample preparation and handling. Now — the numbers.

on the stock market since 1995
2,900 employees
$1.4B market value
WHERE DOES THE MONEY COME FROM?
71%Services
ServicesProducts 29%
71% of all revenue comes from a single line: Services.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$593.8M
The loss that same year:
$55.8M
For every $1 it earns, the company spends $1.1.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

In the vault right now:
$340.9M
DEBT: $111.2M
At this pace, that money lasts about 6.1 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
2.4×

This company is not turning a profit, so the market is pricing its sales instead: 2.4× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 67% of them.

Analysts' average target sits 39% above today's price.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
60
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
52
average

The cash pile is strong; debt and other items pull the grade toward the middle.

VALUATION
67
strong

Clearly above the class average — a step short of the very top.

GROWTH
74
strong

This grade is a blend: the profit side is strong, the sales tempo slow.

PRICE MOMENTUM
74
strong

Clearly above the class average — a step short of the very top.

No real weak spot in any of the five subjects — a balanced report card.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 75% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Sales are holding up

The company sells $593.8M a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/3
Strong cash, light debt

There is $340.9M in the vault; even if every debt were paid off, $229.7M would remain.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 17 buys and 6 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/1
The losses continue

A loss of $55.8M against $593.8M in annual sales.

FINALE · THE GRADE
B+
67 / 100 · MoonshotScore

On our five-subject report card, AZTA sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: AZTA has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film